MAPK1 and neoplasm: The MAPK/ERK signaling is essential for melanoma development and progression—the mutational landscape outlined above shows that the most frequent driving mutations in melanomagenesis are activating mutations of this pathway; moreover, the reactivation of the MAPK signaling by genetic and epigenetic events is the principal mechanism for acquired resistance to target therapy in this tumor (see below).